"The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafenib) to treat patients with advanced gastrointestinal stromal tumors (GIST) that cannot be surgically removed and no longer respond to other FDA-approved t"...
Totect Consumer (continued)
Some products that may interact with this drug include: dimethylsulfoxide (DMSO) products applied to the skin, natalizumab.
OVERDOSE: If overdose is suspected, contact a poison control center or emergency room immediately. US residents can call the US National Poison Hotline at 1-800-222-1222. Canada residents can call a provincial poison control center.
NOTES: Keep all medical appointments while using this medication. Laboratory and/or medical tests (such as complete blood counts, examination of the injection site) should be performed periodically to monitor your progress or check for side effects. Consult your doctor for more details.
MISSED DOSE: For the best possible benefit, it is important to receive each scheduled dose of this medication as directed. If you miss a dose, contact your doctor or pharmacist immediately to establish a new dosing schedule.
STORAGE: Not applicable. This medication is given in a clinic and will not be stored at home.
Information last revised March 2012. Copyright(c) 2012 First Databank, Inc.
Additional Totect Information
Report Problems to the Food and Drug Administration
Get the latest treatment options.